A
Arvinas D
D
ARVN
6.45000
USD
-0.45
(-6.52%)
مغلق
حجم التداول
68,600
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
444,953,979
الأخبار المقالات
العنوان: Arvinas
القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.